Expanded access to phase II clinical trials in oncology: A step toward increasing scientific validity and compassion

被引：0
作者：
Marcee, Alice K. [1 ]
机构：
[1] So Methodist Univ, Dedman Sch Law, Dallas, TX 75275 USA
来源：
FOOD AND DRUG LAW JOURNAL | 2008年 / 63卷 / 02期
关键词：
D O I：
暂无
中图分类号：
TS2 [食品工业];
学科分类号：
0832 ;
摘要：
引用
收藏
页码：439 / 457
页数：19
相关论文
共 50 条
[21]   Precision Oncology Clinical Trials: A Systematic Review of Phase II Clinical Trials with Biomarker-Driven, Adaptive Design [J].
Ha, Hyerim ;
Lee, Hee Yeon ;
Kim, Jee Hyun ;
Kim, Do Yeun ;
An, Ho Jung ;
Bae, SeungJin ;
Park, Hye-sung ;
Kang, Jin Hyoung .
CANCER RESEARCH AND TREATMENT, 2024, 56 (04) :991-1013
[22]   Economic growth of BRIC nations and access to early-phase oncology clinical trials: An overview [J].
Rodrigues, Heloisa Veasey ;
Ganesan, Prasanth ;
Liu, Xiaochun ;
Subbiah, Vivek .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[23]   Validity of Inclusion/Exclusion Criteria in Clinical Trials for Myelofibrosis and the Need for Expanded Access Programs [More Expanded Access Programs Are Needed to Assess the Impact of Comorbidity and Comedication in Patients with Myelofibrosis] [J].
Isfort, Susanne ;
Jost, Edgar ;
Bennemann, Karla ;
Crysandt, Martina ;
Akin, Sema ;
Bruemmendorf, Tim H. ;
Koschmieder, Steffen .
BLOOD, 2012, 120 (21)
[24]   The phase II/III transition: Toward the proof of efficacy in cancer clinical trials [J].
Fazzari, M ;
Heller, G ;
Scher, HI .
CONTROLLED CLINICAL TRIALS, 2000, 21 (04) :360-368
[25]   Re:: Is patient travel distance associated with survival on phase II clinical trials in oncology? [J].
Muñoz, A ;
Samet, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (05) :411-411
[26]   Natural Language Processing for Patient Selection in Phase I or II Oncology Clinical Trials [J].
Delorme, Julie ;
Charvet, Valentin ;
Wartelle, Muriel ;
Lion, Francois ;
Thuillier, Bruno ;
Mercier, Sandrine ;
Soria, Jean-Charles ;
Azoulay, Mikael ;
Besse, Benjamin ;
Massard, Christophe ;
Hollebecque, Antoine ;
Verlingue, Loic .
JCO CLINICAL CANCER INFORMATICS, 2021, 5 :709-718
[27]   Optimal and minimax three-stage designs for phase II oncology clinical trials [J].
Chen, Kun ;
Shan, Michael .
CONTEMPORARY CLINICAL TRIALS, 2008, 29 (01) :32-41
[28]   An Adaptive Design for Phase II Non-Oncology Dose Selection Clinical Trials [J].
Zheng Su .
Clinical Drug Investigation, 2010, 30 :397-403
[29]   Factorial clinical trials: a new approach to phase II neuro-oncology studies [J].
Iwamoto, Fabio M. ;
Lassman, Andrew B. .
NEURO-ONCOLOGY, 2015, 17 (02) :174-176
[30]   Phase II clinical trials in oncology: Strengths and limitations of two-stage designs [J].
Schlesselman, James J. ;
Reis, Isildinha M. .
CANCER INVESTIGATION, 2006, 24 (04) :404-412
12345